尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Martins Eduardo Bruno. Director active across 1 company, notably Sagimet Biosciences Inc.. In total, 6 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €105k. History available since 17 November 2023. The latest transaction was disclosed on 19 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Martins Eduardo Bruno is a declarant linked to Sagimet Biosciences Inc. in the filings listed. He has 6 filings in total, and across the 6 sampled filings from 2023-11-21 to 2026-02-20, sales total EUR 104809 and buys total EUR 0; the modal transaction nature is Attribution.